- Home
- SGMO vs VERI Comparison
SGMO vs VERI Comparison
Compare SGMO & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- VERI
- Stock Information
- Founded
- SGMO 1995
- VERI 2014
- Country
- SGMO United States
- VERI United States
- Employees
- SGMO N/A
- VERI N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- VERI EDP Services
- Sector
- SGMO Health Care
- VERI Technology
- Exchange
- SGMO Nasdaq
- VERI Nasdaq
- Market Cap
- SGMO 122.8M
- VERI 145.4M
- IPO Year
- SGMO 2000
- VERI 2017
- Fundamental
- Price
- SGMO $0.58
- VERI $2.63
- Analyst Decision
- SGMO Buy
- VERI Strong Buy
- Analyst Count
- SGMO 6
- VERI 3
- Target Price
- SGMO $4.50
- VERI $4.00
- AVG Volume (30 Days)
- SGMO 7.8M
- VERI 3.3M
- Earning Date
- SGMO 08-07-2025
- VERI 08-07-2025
- Dividend Yield
- SGMO N/A
- VERI N/A
- EPS Growth
- SGMO N/A
- VERI N/A
- EPS
- SGMO N/A
- VERI N/A
- Revenue
- SGMO $81,706,000.00
- VERI $90,902,000.00
- Revenue This Year
- SGMO $1.29
- VERI $16.39
- Revenue Next Year
- SGMO $1.60
- VERI $22.99
- P/E Ratio
- SGMO N/A
- VERI N/A
- Revenue Growth
- SGMO 565.52
- VERI N/A
- 52 Week Low
- SGMO $0.41
- VERI $1.22
- 52 Week High
- SGMO $3.18
- VERI $5.64
- Technical
- Relative Strength Index (RSI)
- SGMO 58.57
- VERI 57.49
- Support Level
- SGMO $0.50
- VERI $2.57
- Resistance Level
- SGMO $0.58
- VERI $3.06
- Average True Range (ATR)
- SGMO 0.05
- VERI 0.27
- MACD
- SGMO 0.00
- VERI 0.00
- Stochastic Oscillator
- SGMO 84.21
- VERI 62.93
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.